Activity ID
15092Expires
December 31, 2027Format Type
EnduringCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Major Depressive Disorder
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
YesNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Assess optimal timing and clinical rationale for switching or augmenting
treatment in patients with MDD
Evaluate the pharmacologic profiles, efficacy, and safety of approved
adjunctive therapies for adults with MDD that improve residual symptoms,
including anhedonia and cognitive impairment
Apply current guideline-based and evidence-based strategies to optimize
dosing and titration of adjunctive therapies for adults with MDD who
exhibit residual symptoms
Implement strategies for optimizing the management of persistent
symptoms for complex or special populations with MDD to optimize long-
term outcomes and functional recovery
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
